KAT6B and Noonan syndrome: Specifically, such KAT6B alternation enhanced phosphorylation of MEK1/2, ERK, and AKT, which could be reversed when transfecting a high‐expressing KAT6B construct to cells derived from patients with Noonan syndrome [166].